¥
20. 00
+1
+5.2632%
¥
6.11B Market Cap
- P/E Ratio
- Div Yield
212.84M Volume
- Eps
¥ 19
Previous Close Want to track 4564 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
OncoTherapy Science Inc. (4564) Statistics
Valuation metrics
Market Cap 6.11B
Enterprise value 5.88B
Trailing P/E (ttm) -7.22
Forward P/E -0.98
PEG ratio -0.49
Price/Sales (ttm) 9.86
Price/Book (mrq) 4.66
Enterprise Value/Revenue 7.28
Enterprise Value/EBITDA -6.31
Overview
Shares outstanding 338.64M
Float 347.91M
Shares short -
% Held by insiders 0.12%
% Held by institutions 0.01%
Average volume (10 days) 155.25M
Average volume (90 days) 157.03M
Price summary
52-Week low 18
52-Week high 34
Beta 0.28
50-Day moving average 19.57
200-Day moving average 21.22
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 500:1
Last split Date 26 Sep 2013
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 31 Mar 2024
Profitability
Profit margin -1.13%
Operating margin -1.05%
Operational effectiveness
Return on assets -0.39%
Return on equity -0.52%
Income Statement
Revenue (ttm) 808M
Revenue per share (ttm) 1.62
Quarterly revenue growth (yoy) 0.13%
Gross profit (ttm) -521M
EBITDA -
Net income to common (ttm) -910M
Diluted EPS (ttm) -1.82
Quarterly earnings growth (yoy) -0.67%
Balance Sheet
Total cash (mrq) 2.09B
Total cash per share (mrq) 4.19
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 13.59%
Book value per share (mrq) 4.29
Cash Flow
Cash flow statement -922M
Levered free cash flow (LFCF) -674.88M
